Metal labeled peptides for diagnostic imaging in cancer

Informations projet

N° de convention de subvention: QLK3-CT-2000-40562

Projet clôturé

Date de début 15 Mai 2000

Date de fin 14 Mai 2001

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 30 000,00

Contribution de l’UE € 22 500,00

Coordonné par

INBIOS
Italy

Objectif

The research project foresees the development of new molecular entities based onmetal-labeled peptides and peptidomimetics able to target with high affinity and selectivity receptor sites overexposed in human tumours. The receptors identified as the most attractive targets for the engineering of novel diagnostic tools are cholecystokinin and foliate. The new molecules will be used as diagnostic probes in nuclear medicine and magnetic resonance imaging depending upon the coordinated metal. The development of prototype contrast agents suitable for clinical diagnosis costumers in humans is the final goal.

Champ scientifique

• natural sciences › biological sciences › biochemistry › biomolecules
• medical and health sciences › clinical medicine › radiology › nuclear medicine
• medical and health sciences › clinical medicine › oncology
• engineering and technology › medical engineering › diagnostic imaging › magnetic resonance imaging

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-3. - Key action The "Cell factory"

Appel à propositions

Data not available

Régime de financement

EAW - Exploratory awards

Coordinateur

INBIOS

• Contribution de l’UE: Aucune donnée
• Adresse: Via A. Olivetti, 1 ; 80078 POZZUOLI ; Italie
• Coût total: Aucune donnée

Participants (1)

ISOGEN BIOSCIENCE BV

Pays-Bas

• Contribution de l’UE: Aucune donnée
• Adresse: Industrieweg 68 ; 3606 AS MAARSSEN
• Coût total: Aucune donnée